Clinical and Pathogenetic Features of Hyperprolactinemia and Anovulatory Dysfunction in Women With Hypothyroidism

Authors

  • Yo‘ldosheva Nozanin To‘ra qizi Termiz Branch, Tashkent State Medical University, Uzbekistan
  • Xolova Zarina Baymuradovna Scientific Supervisor, t. f.n (PhD) Termiz Branch, Tashkent State Medical University, Uzbekistan

Keywords:

Insufficient thyroid function, hyperprolactinemia, anovulatory dysfunction, menstrual irregularities, infertility, hormonal therapy, reproductive health, clinical features

Abstract

This article investigates the clinical and pathogenetic characteristics of hyperprolactinemia and anovulatory dysfunction in women with insufficient thyroid function. Insufficient thyroid function leads to increased prolactin secretion, which disrupts the normal hormonal regulation of the ovaries, resulting in menstrual irregularities, ovulation failure, and infertility. The study analyzes epidemiological data, pathophysiological mechanisms, clinical manifestations, diagnostic approaches, and treatment strategies. Early detection and appropriate hormonal therapy, including thyroid hormone replacement and prolactin-lowering interventions, are essential to restore reproductive function. Understanding these interactions is critical for improving fertility outcomes and providing evidence-based management for affected women.

References

1. Khan, A. A., Sharma, R., & Ata, F. (2025). Systematic review of the association between thyroid disorders and hyperprolactinemia. Thyroid Research, 18(1), 1–15.

2. Valvekar, U., Lakshmi, S., & Kumar, A. N. (2024). Hypothyroidism and hyperprolactinemia correlation in women with primary and secondary infertility. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 9(3), 120–128.

3. Purohit, J., Barjatya, R., & Kataria, S. K. (2023). Evaluation of hyperprolactinemia and thyroid disorder among women with dysfunctional uterine bleeding at a tertiary care hospital of western Rajasthan. Scholars International Journal of Anatomy and Physiology, 6(1), 34–42.

4. nonymous. (1978). Prevalence of hyperprolactinemia in anovulatory women. Journal of Clinical Endocrinology and Metabolism, 47(3), 718–725.

5. Aytieva, A., & Karimzhanova, M. (2023). Syndrome of hyperprolactinemia: Clinical case example. Vestnik Oshskogo Gosudarstvennogo Universiteta. Medicina, 14(4), 102–110.

6. Smagulov, B. (2022). Methods of treatment of hyperprolactinemia in combination with hypothyroidism: Literature review. Nauka i Zdravookhranenie, 9(6), 259–267.

Downloads

Published

2025-12-20

How to Cite

To‘ra qizi, Y. N., & Baymuradovna, X. Z. (2025). Clinical and Pathogenetic Features of Hyperprolactinemia and Anovulatory Dysfunction in Women With Hypothyroidism. International Journal of Integrative and Modern Medicine, 3(12), 191–195. Retrieved from https://medicaljournals.eu/index.php/IJIMM/article/view/2487

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.